Table 3.
Multivariate analysis for Anti-S antibody response to COVID-19 vaccines among the migrant workers, Bangladesh, 2021-22.
| Variables | Coefficient | P-value* | 95% CI |
|---|---|---|---|
| Vaccine Doses | |||
| Single dose | Ref | ||
| Double dose | 1181.428 | <0.001 | (1153.132, 1209.723) |
| Booster dose | 17839.58 | <0.001 | (17741.03, 17938.14) |
| Different COVID-19 Vaccines | |||
| AstraZeneca (Covishield) | Ref | ||
| Moderna (Spikevax) | 5679.379 | <0.001 | (5648.231, 5710.527) |
| Pfizer (Comirnaty) | 3557 | <0.001 | (3526.803, 3587.197) |
| Sinopharm (BBIBP-CorV) | -6234.395 | <0.001 | (-6261.249, -6207.542) |
| Past SARS-CoV-2 infection | |||
| No | Ref | ||
| Yes | 3347.866 | <0.001 | (3321.804, 3373.928) |
| Anti-N Antibody | |||
| Negative | Ref | ||
| Positive | 2375.98 | <0.001 | (2348.739, 2403.221) |
*P value is generated by Poisson regression.